The outcome of COVID‐19 in patients with hematological malignancy

I have read with great interest the recently published paper by Yigenoglu et al. entitled, “The outcome of COVID‐19 in patients with hematological malignancy”.

Saved in:
Bibliographic Details
Published in:Journal of Medical Virology 2021-03, Vol.93 (3), p.1229-1229
Main Author: Cakir, Banu
Format: Article
Language:English
Subjects:
Actin Depolymerizing Factors
CD4-Positive T-Lymphocytes
Cell Movement
COVID-19
Hematologic Neoplasms - complications
Hematology
HIV Infections
Humans
Immune Reconstitution
Letter to the Editor
Letters to the Editor
Malignancy
SARS-CoV-2
Virology
Citations: Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:I have read with great interest the recently published paper by Yigenoglu et al. entitled, “The outcome of COVID‐19 in patients with hematological malignancy”.
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.26576